Modafinil

CAS 68693-11-8 11 current records 4 historicalSmall Molecule

Who holds supplier records for Modafinil? 11 organisations hold a current record for Modafinil: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), Netherlands (2), Israel (1), United States (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Modafinil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/modafinil

Reading the evidence

  • 11 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (11)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Modafinil. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Modafinil sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Modafinil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
WAVELENGTH ENTERPRISES LTD. Petah TikvaIL
CEP 2013-213 - Rev 05
Modafinil
Jul 2026—
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2024-098 - Rev 02
Modafinil
Jul 2026—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2014-073 - Rev 01
Modafinil
Dec 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2008-199 - Rev 05
Modafinil
Sept 2025—
TAPI NL B.V. AmsterdamNL
CEP 2009-331 - Rev 05
Modafinil
Jul 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2013-053 - Rev 01
Modafinil
Jan 2024—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2022-186 - Rev 00
Modafinil
Dec 2023—
ORBION PHARMACEUTICALS PRIVATE LIMITED IrungattukottaiIN
R1-CEP 2008-053 - Rev 05
Modafinil
Apr 2022—
TEVA PHARMA B.V. UtrechtNL
R1-CEP 2006-089 - Rev 01
Modafinil
May 2013—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Modafinil are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Overview

Modafinil is a wakefulness-promoting agent approved for the treatment of narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is thought to work by altering the natural chemicals (neurotransmitters) in the brain.

Chemical identity

IUPAC name
2-benzhydrylsulfinylacetamide
Canonical SMILES
C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)CC(=O)N
InChIKey
YFGHCGITMMYXAQ-UHFFFAOYSA-N
Synonyms
Provigil API, (±)-modafinil, cep 1538, cep-1538, crc-40476, crl 40476, crl-40476, dep-1538, modafinil civ, modaphonil, modiodal, nsc-751178

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Sympathomimetic-like Agent
Physiologic effect
Central Nervous System Stimulation; Increased Sympathetic Activity

Therapeutic areas

NarcolepsyShift Work Sleep DisorderObstructive Sleep Apnea

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Modafinil?

11 organisations hold an active US FDA Type II Drug Master File or a CEP for Modafinil: Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), MATRIX PHARMACORP PRIVATE LTD (India), ORBION PHARMACEUTICALS PRIVATE LTD (India), TAPI NL BV (Netherlands), Viyash Scientific Ltd (India) and WAVELENGTH ENTERPRISES LTD (Israel), and 3 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Modafinil Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 16477), APITORIA PHARMA PRIVATE LTD (DMF 23898), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 36975), MATRIX PHARMACORP PRIVATE LTD (DMF 16306), ORBION PHARMACEUTICALS PRIVATE LTD (DMF 19645), TAPI NL BV (DMF 16310), Viyash Scientific Ltd (DMF 38533) and WAVELENGTH ENTERPRISES LTD (DMF 16140) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Modafinil records mean?

4 organisations have only inactive Type II DMFs for Modafinil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Modafinil have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Modafinil on the EDQM register, including WAVELENGTH ENTERPRISES LTD. Petah Tikva (IL), VIYASH SCIENTIFIC LIMITED Hyderabad (IN), ALEMBIC PHARMACEUTICALS LIMITED Vadodara (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), TAPI NL B.V. Amsterdam (NL) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Modafinil supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Modafinil?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.